Olanib 150 mg 120 Tablets | Olaparib

Olanib 150 mg (120 Tablets) used to treat adult patients epithelial ovarian, fallopian tube or primary peritoneal cancer and EGFR-2 negative breast cancer. It is used alone or in combination with Bevacizumab to treat Ovarian cancer, Fallopian Tube Cancer and Peritoneal cancer in adult patients who have received their first therapy successfully.

Olanib is a targeted therapy, works by blocking the protein that stimulates cancer cells to grow.

Dosage and Administration

Tablets available as 100 mg and 150 mg dosage and modification are different for different types of cancer

Ovarian cancer

• To treat recurrent ovarian cancer 300 mg Olanib by mouth two times a day until disease progression or unacceptable toxicity.
• For advance ovarian cancer 300 mg Olanib by mouth two times a day until disease progression or 2 years settlement.
• Advance ovarian cancer in combination with Bevacizumab 300 mg olanib plus 15 mg/kg bevacizumab in every 3 weeks for a total 15 months includinig chemotherapy and maintainance. Patients with complete response stop treatment after two years. Otherwise patient can continue with evidence of disease.

Breast Cancer

• 300 mg Olanib daily twice by mouth until disease progression or for total one year which one happens first.

For Pancreatic cancer and metastatic castration resistant prostate cancer 300 mg of olanib should be used until disease progression or unacceptable toxicity.

Pregnancy and Lactation

Based on findings from animal studies, research on animal rats shows this statistics that taking olanib during pregnancy have a risk of fetal harm to fetus. Childbearing potential women should take proper contraception during treatment and for at least six month after treatment. Based on findings from reproductive studies, male patient should also take proper contraception during treatment and should not donate sperm after 3 months of treatment.

Women who are feeding breast to their children are advise not to feed breast milk at least one month after of treatment.

Side Effects

The most common adverse side effects dermatitis allergic, neutrophil count decreased and platelet count decreased.

Storage

Store below 30 degree C and in a dry place away from light and children.

FAQs about Olanib 150 mg 120 Tablets (Olaparib)

Who manufacture Olanib 150 mg?

Olanib has two varient 100 mg and 150 mg, It is manufactured by Everest Pharmaceutical.

What is the price of Olanib 150 mg for 120 tablets?

Olanib 150 mg 120 tablets will cost $500 and olanib 50 mg will cost $300.

What if I miss a dose of Olanib or take an over dose?

If you do so immediately contact with your doctor or health care professional.

See similar product Olarigen by general pharma which is cheaper than olanib.